Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5678516 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10MGLLCES2CES1 | |
| Ammonia Solution, Strong SCHEMBL19874816 | 0.96 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL17036060 | 0.96 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL6666401 | 0.96 | ALDH1A1 (0.32) | ALDH1A1HSD17B10MGLL | |
| SCHEMBL1020187 | 0.96 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL17036062 | 0.92 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL5952321 | 0.69 | — | — | |
| SCHEMBL8953858 | 0.69 | EPHX1 (0.32) | ALDH1A1HSD17B10 | |
| SCHEMBL12452972 | 0.69 | CES2 (0.33) | ALDH1A1HSD17B10CES2CES1 | |
| SCHEMBL22626103 | 0.69 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1677 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026086465-A1 | INTERFERENCE SINGLE MOLECULE LOCALIZATION MICROSCOPIC IMAGING APPARATUS BASED ON SPECULAR REFLECTION AND SINGLE OBJECTIVE LENS, AND IMAGING METHOD | 西湖大学 | 2026-04-30 | — | — | WO | claimed |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2026-04-23 | — | — | US | claimed |
| EP-4676949-A2 | ANTIGEN BINDING MOLECULES AND METHODS OF USE | Kite Pharma, Inc. (US) | 2026-01-14 | — | — | EP | claimed |
| EP-4662486-A1 | CAPILLARY ELECTROPHORESIS FOR BIOMOLECULE ENCAPSULATION EFFICIENCY DETERMINATION | DH Technologies Development Pte. Ltd. (SG) | 2025-12-17 | — | — | EP | claimed |
| US-12498324-B2 | Methods and compositions for retrieving cellular structures based on spatiotemporal profiles | BAYLOR COLLEGE OF MEDICINE (US) | 2025-12-16 | — | — | US | claimed |
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | FREISTAAT BAYERN LUDWIG MAXIMILIANS UNIV MUENCHEN (DE) | 2025-12-11 | — | — | US | claimed |
| US-20250377334-A1 | ADENO-ASSOCIATED VIRUS VECTORS EMPTY/FULL RATIO ANALYSIS USING CE-BASED GENOME AND CAPSID QUANTIFICATION | DH TECHNOLOGIES DEV PTE LTD (SG) | 2025-12-11 | — | — | US | claimed |
| US-20250368604-A1 | MASP-2 INHIBITORS AND METHODS OF USE | OMEROS CORPORATION (US) | 2025-12-04 | — | — | US | claimed |
| EP-4651910-A1 | DUAL LABELLED COMPOUNDS TARGETING THE PROSTATE SPECIFIC MEMBRANE ANTIGEN | Centre Hospitalier Universitaire Vaudois (CHUV) (CH) | 2025-11-26 | — | — | EP | claimed |
| WO-2025227196-A1 | ELECTROCHEMICAL FLUORESCENCE MODULATION FOR MULTICOLOUR IMAGING TECHNIQUES | NEWSOUTH INNOVATIONS PTY LIMITED (AU) | 2025-11-06 | — | — | WO | claimed |
| CN-1303386-A | Synthesis method of alkali metal substituted borohydride reagent | MINE SAFETY APPLIANCES CO (US) | 2001-07-11 | — | — | CN | claimed |
| WO-2000043400-A1 | SYNTHESIS OF ALKALI METAL SUBSTITUTED BOROHYDRIDE REAGENTS | MINE SAFETY APPLIANCES COMPANY (US) | 2000-07-27 | — | — | WO | claimed |
| US-5886229-A | ONE STEP CATALYTIC HYDROGENATION BY REACTING AN ALKALI METAL, A HYDROGEN DONOR, AND A TRISUBSTITUTED BORANE | MINE SAFETY APPLIANCES COMPANY (US) | 1999-03-23 | — | — | US | claimed |
| US-5254786-A | Contacting with supported molybdenum or rhenium catalyst promoted with an organoborane compound | SHELL OIL COMPANY (US) | 1993-10-19 | — | — | US | claimed |
| US-5098876-A | A molybdenum-rhenium oxide catalyst with an organoboron promoter for disproportionation reactions | SHELL OIL COMPANY (US) | 1992-03-24 | — | — | US | claimed |
| US-5057644-A | Catalytic ethylation | SHELL OIL COMPANY (US) | 1991-10-15 | — | — | US | claimed |
| US-4312967-A | CHROMIUM OXIDE ON TITANIUM-CONTAINING SILICA SUPPORT IN COMBINATION WITH ORGANOBORON PROMOTER | PHILLIPS PETROLEUM CO. (US) | 1982-01-26 | — | — | US | claimed |
| EP-0035124-A1 | Polymerization catalyst and polymerization process | PHILLIPS PETROLEUM COMPANY (US) | 1981-09-09 | — | — | EP | claimed |
| US-4196279-A | BORANE OR METAL TETRAHYDROCARBYLBORON | TEIJIN LIMITED (JP) | 1980-04-01 | — | — | US | claimed |
| US-3989882-A | Process for preparing an alternating copolymer of a conjugated vinyl compound and an olefinic unsaturated compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-02 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250377301-A1 | STABILISED FLUOROPHORES, COMPOSITIONS, METHODS OF PREPARATION, CONJUGATES THEREOF, AND METHODS OF USE | CRY1, MKI67, IK | ALDH1A1 1061/4885HSD17B10 3731/4885MGLL 4625/4885 |
| US-20250368604-A1 | MASP-2 INHIBITORS AND METHODS OF USE | MASP2, METAP2, SPINT2 | ALDH1A1 4701/4885HSD17B10 3043/4885MGLL 915/4885 |
| US-20260108619-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | DCLRE1A, CCR3, CCR8 | ALDH1A1 2641/4885HSD17B10 3355/4885MGLL 3960/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.